Try our beta test site

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

This study has been completed.
Sponsor:
Collaborators:
The 4C trial bureau
Japan Heart Foundation
Information provided by (Responsible Party):
Hisao Ogawa, Kumamoto University
ClinicalTrials.gov Identifier:
NCT00139386
First received: August 29, 2005
Last updated: April 17, 2013
Last verified: April 2013